Nutritional Regulation of Leukocyte Function
FPP Supplement
1 other identifier
interventional
31
1 country
1
Brief Summary
The objective of the current study is to determine the dose at which Fermented Papaya Preparation ( FPP) is able to improve inducible respiratory burst outcomes in peripheral blood mononuclear cells (PBMC) and neutrophils of participants. Our investigators have reported that supplementation with standardized fermented papaya preparation (FPP) in mice improves dermal wound healing outcomes. Therefore, based on these observations, the investigators propose to study the dose at which FPP supplementation induces respiratory burst in blood-derived myeloid cells in healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2021
CompletedFirst Posted
Study publicly available on registry
January 13, 2022
CompletedStudy Start
First participant enrolled
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedAugust 21, 2023
August 1, 2023
5 months
December 2, 2021
August 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reactive Oxygen species (ROS) production of Leucocytes 6 weeks post supplementation
The major objectives of the study is to study the mechanism of action on ROS production by leucocytes of healthy subjects post 6 weeks FPP supplementation measured by flowcytometry
6 weeks post supplementation
Blood leukocyte phagocytosis 6 weeks post supplementation
Blood leukocyte phagocytosis 6 weeks post supplementation via cell biology technique
6 weeks post supplementation
Secondary Outcomes (1)
Leukocyte activation and cytokine production at 6 wks post supplementation
5 weeks
Study Arms (4)
control
NO INTERVENTIONno supplements will be taken
3 grams of supplements
EXPERIMENTALsubjects will take 3 grams of supplements once per day
6 grams of supplements
EXPERIMENTALsubjects will take 3 grams of supplements twice per day
9 grams of supplements
EXPERIMENTALsubjects will take 3 grams of supplements three times per day
Interventions
Participants will take the supplements per randomization
Eligibility Criteria
You may qualify if:
- Ages 18 and above
- Subjects must be able to follow directions and give informed consent on their own
You may not qualify if:
- Individuals who are deemed unable to understand the procedures, risks and benefits of the study, ie. Informed consent will be excluded.
- Females who are pregnant will also be excluded to minimize the risk to such individuals (and fetus).
- Individuals who are therapeutically immuno-compromised will also be excluded to decrease statistical variability and to minimize potential of confounders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Osato Research Institutecollaborator
Study Sites (1)
Indiana University Health Methodist Hospital
Indianapolis, Indiana, 46228, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Sashwati Roy, PhD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
December 2, 2021
First Posted
January 13, 2022
Study Start
February 15, 2022
Primary Completion
July 8, 2022
Study Completion
July 31, 2023
Last Updated
August 21, 2023
Record last verified: 2023-08